OVERVIEW
Morgan is a partner in Maples and Calder's Corporate team in the Maples Group's Dublin office. He specialises in corporate law and has a broad corporate and commercial practice including advising Irish and international clients on domestic and cross-border mergers and acquisitions, venture capital and private equity transactions, joint ventures, loan portfolio transactions and corporate reorganisations. Morgan's transactional experience and expertise lies across a vast range of industries, with a particular focus in recent years on the financial services and technology sectors.
BACKGROUND
Morgan joined the Maples Group in 2021. He previously worked for a large Irish corporate law firm from 2009 to 2020. Morgan has been recommended by The Legal 500 EMEA.
RECENT TRANSACTIONS
- AMCS Group on various acquisitions
- Arachas Corporate Brokers on its acquisition of BJP Insurance
- Boxever on its sale to Sitecore
- Cardinal Capital Group on its Irish investments
- Mercuria Energy Group and Lacerta Partners on their investment in Exergyn
- Taxamo on its sale to Vertex
- Welltel on its acquisition of Strencom
AREAS OF EXPERTISE
BAR ADMISSIONS
2012 – Admitted as a solicitor in Ireland
EDUCATION
Bachelor of Business and Law (First Class Honours), University College Dublin, 2008
PROFESSIONAL ACTIVITIES
GET IN TOUCH
For expert advice, contact us today - we'd love to hear from you. Please fill in the form and we will contact you as soon as possible.
KNOWLEDGE
- Ireland Update: GDPR Fourth Anniversary 25 May 2022
- Largest Unfair Dismissal Compensation Award Ordered - Update for Employers in Ireland 24 May 2022
- Central Bank of Ireland Approval Process for UCITS Side Pocketing Arrangements 24 May 2022
- ICLG Aviation Finance and leasing 2022 Cayman Islands 24 May 2022
- Interim Receivership Orders Cross Undertaking Requirement Clarified 20 May 2022
NEWS & DEALS
- Maples Group Welcomes 13 New Associates to its Irish Law Firm 20 May 2022
- Maples Advises Biohaven in Largest Take-Private Transaction in BVI 19 May 2022
- Maples Advises on First Royalty-Backed Financing in China's Biopharmaceutical Industry 04 May 2022
- Maples Group Achieves ISO 27001 Certification 28 April 2022
- Maples Group Recognised for Excellence in Europe 26 April 2022